nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.104	0.163	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.102	0.16	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0975	0.153	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0789	0.123	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0694	0.109	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0595	0.0931	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0537	0.084	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0415	0.0649	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0321	0.0502	CbGbCtD
Dinoprost Tromethamine—TBXA2R—endothelium—acquired immunodeficiency syndrome	0.00647	0.0712	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood plasma—acquired immunodeficiency syndrome	0.00574	0.0632	CbGeAlD
Dinoprost Tromethamine—GALR3—retina—acquired immunodeficiency syndrome	0.00532	0.0585	CbGeAlD
Dinoprost Tromethamine—HPGDS—blood plasma—acquired immunodeficiency syndrome	0.00382	0.0421	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—acquired immunodeficiency syndrome	0.00351	0.0386	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood plasma—acquired immunodeficiency syndrome	0.00311	0.0343	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood—acquired immunodeficiency syndrome	0.0021	0.0232	CbGeAlD
Dinoprost Tromethamine—TBXA2R—vagina—acquired immunodeficiency syndrome	0.00195	0.0215	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lung—acquired immunodeficiency syndrome	0.00184	0.0203	CbGeAlD
Dinoprost Tromethamine—PTGER3—digestive system—acquired immunodeficiency syndrome	0.0017	0.0187	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—retina—acquired immunodeficiency syndrome	0.00151	0.0166	CbGeAlD
Dinoprost Tromethamine—PTGER1—nervous system—acquired immunodeficiency syndrome	0.0015	0.0165	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymphoid tissue—acquired immunodeficiency syndrome	0.00149	0.0164	CbGeAlD
Dinoprost Tromethamine—HPGDS—digestive system—acquired immunodeficiency syndrome	0.00147	0.0162	CbGeAlD
Dinoprost Tromethamine—PTGER1—central nervous system—acquired immunodeficiency syndrome	0.00144	0.0159	CbGeAlD
Dinoprost Tromethamine—PTGER3—lung—acquired immunodeficiency syndrome	0.00142	0.0156	CbGeAlD
Dinoprost Tromethamine—HPGDS—blood—acquired immunodeficiency syndrome	0.0014	0.0154	CbGeAlD
Dinoprost Tromethamine—HPGDS—bone marrow—acquired immunodeficiency syndrome	0.00135	0.0149	CbGeAlD
Dinoprost Tromethamine—HPGDS—spinal cord—acquired immunodeficiency syndrome	0.00135	0.0148	CbGeAlD
Dinoprost Tromethamine—PTGER3—nervous system—acquired immunodeficiency syndrome	0.00131	0.0145	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—skin of body—acquired immunodeficiency syndrome	0.00131	0.0144	CbGeAlD
Dinoprost Tromethamine—TBXA2R—brain—acquired immunodeficiency syndrome	0.00131	0.0144	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—acquired immunodeficiency syndrome	0.0013	0.0143	CbGeAlD
Dinoprost Tromethamine—PTGER3—central nervous system—acquired immunodeficiency syndrome	0.00127	0.0139	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—acquired immunodeficiency syndrome	0.00126	0.0139	CbGeAlD
Dinoprost Tromethamine—HPGDS—lung—acquired immunodeficiency syndrome	0.00123	0.0135	CbGeAlD
Dinoprost Tromethamine—PTGIR—digestive system—acquired immunodeficiency syndrome	0.0012	0.0132	CbGeAlD
Dinoprost Tromethamine—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.00117	0.0128	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood—acquired immunodeficiency syndrome	0.00114	0.0126	CbGeAlD
Dinoprost Tromethamine—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.00114	0.0125	CbGeAlD
Dinoprost Tromethamine—HPGDS—nervous system—acquired immunodeficiency syndrome	0.00114	0.0125	CbGeAlD
Dinoprost Tromethamine—PTGFR—lung—acquired immunodeficiency syndrome	0.00113	0.0125	CbGeAlD
Dinoprost Tromethamine—PTGIR—spinal cord—acquired immunodeficiency syndrome	0.0011	0.0121	CbGeAlD
Dinoprost Tromethamine—HPGDS—central nervous system—acquired immunodeficiency syndrome	0.00109	0.012	CbGeAlD
Dinoprost Tromethamine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.00101	0.0112	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—blood—acquired immunodeficiency syndrome	0.00101	0.0111	CbGeAlD
Dinoprost Tromethamine—PTGER3—brain—acquired immunodeficiency syndrome	0.001	0.0111	CbGeAlD
Dinoprost Tromethamine—PTGIR—lung—acquired immunodeficiency syndrome	0.001	0.011	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—acquired immunodeficiency syndrome	0.000971	0.0107	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—spinal cord—acquired immunodeficiency syndrome	0.00097	0.0107	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—acquired immunodeficiency syndrome	0.000933	0.0103	CbGeAlD
Dinoprost Tromethamine—PTGIR—nervous system—acquired immunodeficiency syndrome	0.000926	0.0102	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—vagina—acquired immunodeficiency syndrome	0.000924	0.0102	CbGeAlD
Dinoprost Tromethamine—PTGIR—central nervous system—acquired immunodeficiency syndrome	0.000892	0.00982	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lung—acquired immunodeficiency syndrome	0.000883	0.00972	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lung—acquired immunodeficiency syndrome	0.000874	0.00962	CbGeAlD
Dinoprost Tromethamine—HPGDS—brain—acquired immunodeficiency syndrome	0.000868	0.00956	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—acquired immunodeficiency syndrome	0.000839	0.00924	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—nervous system—acquired immunodeficiency syndrome	0.000817	0.009	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—nervous system—acquired immunodeficiency syndrome	0.00081	0.00891	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—central nervous system—acquired immunodeficiency syndrome	0.000787	0.00866	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—central nervous system—acquired immunodeficiency syndrome	0.000779	0.00858	CbGeAlD
Dinoprost Tromethamine—PTGFR—lymph node—acquired immunodeficiency syndrome	0.000776	0.00855	CbGeAlD
Dinoprost Tromethamine—PTGIR—brain—acquired immunodeficiency syndrome	0.000708	0.00779	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—acquired immunodeficiency syndrome	0.000684	0.00753	CbGeAlD
Dinoprost Tromethamine—SLC22A7—brain—acquired immunodeficiency syndrome	0.000673	0.00741	CbGeAlD
Dinoprost Tromethamine—SLC22A6—brain—acquired immunodeficiency syndrome	0.00065	0.00716	CbGeAlD
Dinoprost Tromethamine—SLC22A8—blood—acquired immunodeficiency syndrome	0.000627	0.00691	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—brain—acquired immunodeficiency syndrome	0.000625	0.00688	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—brain—acquired immunodeficiency syndrome	0.000619	0.00681	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lymph node—acquired immunodeficiency syndrome	0.000604	0.00665	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—acquired immunodeficiency syndrome	0.000598	0.00658	CbGeAlD
Dinoprost Tromethamine—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000509	0.00561	CbGeAlD
Dinoprost Tromethamine—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.00049	0.0054	CbGeAlD
Dinoprost Tromethamine—SLC22A8—brain—acquired immunodeficiency syndrome	0.000389	0.00428	CbGeAlD
Dinoprost Tromethamine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00197	CcSEcCtD
Dinoprost Tromethamine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00197	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000347	0.00196	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000346	0.00196	CcSEcCtD
Dinoprost Tromethamine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00196	CcSEcCtD
Dinoprost Tromethamine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00195	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00194	CcSEcCtD
Dinoprost Tromethamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000343	0.00194	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00194	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000343	0.00194	CcSEcCtD
Dinoprost Tromethamine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000342	0.00194	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00193	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00193	CcSEcCtD
Dinoprost Tromethamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000341	0.00193	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00193	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00193	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00192	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000339	0.00192	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.00192	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00192	CcSEcCtD
Dinoprost Tromethamine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00191	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00191	CcSEcCtD
Dinoprost Tromethamine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.00191	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000336	0.0019	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000335	0.0019	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000335	0.0019	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000334	0.00189	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00188	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00188	CcSEcCtD
Dinoprost Tromethamine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.00188	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00187	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.00187	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.00186	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00186	CcSEcCtD
Dinoprost Tromethamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.00186	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.00184	CcSEcCtD
Dinoprost Tromethamine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.00183	CcSEcCtD
Dinoprost Tromethamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000323	0.00183	CcSEcCtD
Dinoprost Tromethamine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00182	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000321	0.00182	CcSEcCtD
Dinoprost Tromethamine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00032	0.00181	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00032	0.00181	CcSEcCtD
Dinoprost Tromethamine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00181	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.0018	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.0018	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.0018	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000317	0.0018	CcSEcCtD
Dinoprost Tromethamine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.00179	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00179	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000315	0.00179	CcSEcCtD
Dinoprost Tromethamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00179	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00178	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00177	CcSEcCtD
Dinoprost Tromethamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000313	0.00177	CcSEcCtD
Dinoprost Tromethamine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00177	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00177	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000312	0.00177	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000312	0.00177	CcSEcCtD
Dinoprost Tromethamine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00176	CcSEcCtD
Dinoprost Tromethamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000311	0.00176	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00176	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.00175	CcSEcCtD
Dinoprost Tromethamine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00175	CcSEcCtD
Dinoprost Tromethamine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00175	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00175	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000309	0.00175	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00175	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00175	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00174	CcSEcCtD
Dinoprost Tromethamine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00174	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.00174	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000306	0.00173	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.00173	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000305	0.00173	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000305	0.00173	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000304	0.00172	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00172	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00172	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00172	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00171	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.0003	0.0017	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.0017	CcSEcCtD
Dinoprost Tromethamine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.0017	CcSEcCtD
Dinoprost Tromethamine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00169	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.00168	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00168	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00168	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00168	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000295	0.00167	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00167	CcSEcCtD
Dinoprost Tromethamine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00167	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000295	0.00167	CcSEcCtD
Dinoprost Tromethamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000295	0.00167	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00166	CcSEcCtD
Dinoprost Tromethamine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00166	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00166	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00166	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00165	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00164	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00163	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00163	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00162	CcSEcCtD
Dinoprost Tromethamine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00162	CcSEcCtD
Dinoprost Tromethamine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00162	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000286	0.00162	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000285	0.00161	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000285	0.00161	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00161	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00161	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000284	0.00161	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.0016	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00159	CcSEcCtD
Dinoprost Tromethamine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.00159	CcSEcCtD
Dinoprost Tromethamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000281	0.00159	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000281	0.00159	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00159	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00028	0.00159	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00158	CcSEcCtD
Dinoprost Tromethamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000279	0.00158	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00158	CcSEcCtD
Dinoprost Tromethamine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00158	CcSEcCtD
Dinoprost Tromethamine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00156	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.00156	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00156	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00156	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.00156	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000274	0.00155	CcSEcCtD
Dinoprost Tromethamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000272	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000272	0.00154	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00154	CcSEcCtD
Dinoprost Tromethamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00154	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.00153	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00153	CcSEcCtD
Dinoprost Tromethamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.00153	CcSEcCtD
Dinoprost Tromethamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00027	0.00153	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00027	0.00153	CcSEcCtD
Dinoprost Tromethamine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.00152	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00152	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00152	CcSEcCtD
Dinoprost Tromethamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000267	0.00151	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000267	0.00151	CcSEcCtD
Dinoprost Tromethamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000266	0.0015	CcSEcCtD
Dinoprost Tromethamine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.0015	CcSEcCtD
Dinoprost Tromethamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.0015	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.0015	CcSEcCtD
Dinoprost Tromethamine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00149	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00148	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00148	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00147	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00147	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00147	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00147	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00146	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00146	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.00146	CcSEcCtD
Dinoprost Tromethamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000257	0.00145	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00145	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00145	CcSEcCtD
Dinoprost Tromethamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000256	0.00145	CcSEcCtD
Dinoprost Tromethamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000252	0.00143	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00142	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00141	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00141	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00141	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00141	CcSEcCtD
Dinoprost Tromethamine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00141	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00141	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00141	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.0014	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00139	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00137	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00136	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00136	CcSEcCtD
Dinoprost Tromethamine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00136	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00135	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00135	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00135	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00135	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00135	CcSEcCtD
Dinoprost Tromethamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00134	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00134	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00134	CcSEcCtD
Dinoprost Tromethamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.00133	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00132	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00131	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00131	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00023	0.0013	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.0013	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.0013	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.0013	CcSEcCtD
Dinoprost Tromethamine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00129	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.00128	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00127	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00126	CcSEcCtD
Dinoprost Tromethamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00126	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00125	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00125	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00125	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00022	0.00235	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00125	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00022	0.00235	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00124	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00124	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00124	CcSEcCtD
Dinoprost Tromethamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000218	0.00123	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00123	CcSEcCtD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000216	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000216	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000216	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000216	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00122	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00121	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000214	0.00229	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000214	0.00228	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000211	0.00226	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.0012	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.0012	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00118	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00118	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00118	CcSEcCtD
Dinoprost Tromethamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00117	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00117	CcSEcCtD
Dinoprost Tromethamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000207	0.00117	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00117	CcSEcCtD
Dinoprost Tromethamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00117	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00117	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000202	0.00216	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00114	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000201	0.00214	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00113	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00113	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000199	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00112	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00112	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00112	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000198	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00111	CcSEcCtD
Dinoprost Tromethamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00111	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000194	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000194	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000194	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000193	0.00206	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00109	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00109	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00109	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.00019	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00019	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00107	CcSEcCtD
Dinoprost Tromethamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00106	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000186	0.00198	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000186	0.00198	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00105	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00105	CcSEcCtD
Dinoprost Tromethamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00104	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00104	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00104	CcSEcCtD
Dinoprost Tromethamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00103	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000182	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000182	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000179	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00101	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000177	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.001	CcSEcCtD
Dinoprost Tromethamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.001	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000999	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000176	0.00187	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000994	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000175	0.00187	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000175	0.00187	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000173	0.00185	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000173	0.00185	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000979	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000171	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000171	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000171	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000962	CcSEcCtD
Dinoprost Tromethamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000954	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000953	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000168	0.0018	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000168	0.0018	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000168	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000168	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000948	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000167	0.00178	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000942	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000165	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000164	0.00175	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000161	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000161	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00016	0.00171	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000899	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000157	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000157	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000154	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000154	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000151	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000151	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00015	0.0016	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000149	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000148	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000148	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000145	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000145	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000144	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000144	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000141	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000141	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000141	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000138	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000136	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000136	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000136	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000135	0.00144	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00013	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00013	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00013	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000128	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000128	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000128	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000127	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000127	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000126	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000125	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000125	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000125	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000124	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000123	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000117	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000115	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000115	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000113	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000113	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000113	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00011	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000109	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000109	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000107	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000106	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000104	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000103	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000102	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000102	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000101	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.99e-05	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.94e-05	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.94e-05	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.9e-05	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.9e-05	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.75e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.75e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.74e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.71e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.71e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.67e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.66e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.66e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.59e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.53e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.51e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.51e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.5e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.5e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.5e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.5e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.31e-05	0.000994	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.31e-05	0.000994	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.31e-05	0.000994	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.31e-05	0.000994	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.18e-05	0.00098	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.06e-05	0.000967	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.99e-05	0.00096	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.99e-05	0.00096	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.89e-05	0.000949	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IL2—acquired immunodeficiency syndrome	8.83e-05	0.000943	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.78e-05	0.000938	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.78e-05	0.000937	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.77e-05	0.000937	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.71e-05	0.00093	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.65e-05	0.000924	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.63e-05	0.000922	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.63e-05	0.000922	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.59e-05	0.000918	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.59e-05	0.000918	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.45e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.45e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.45e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.45e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.04e-05	0.000859	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.02e-05	0.000856	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.91e-05	0.000845	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	7.62e-05	0.000813	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.56e-05	0.000807	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.56e-05	0.000807	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.42e-05	0.000792	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.31e-05	0.00078	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.25e-05	0.000775	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.23e-05	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	7.23e-05	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.2e-05	0.000769	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—ALB—acquired immunodeficiency syndrome	7.19e-05	0.000768	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.12e-05	0.000761	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.08e-05	0.000756	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.08e-05	0.000756	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.97e-05	0.000745	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.97e-05	0.000745	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	6.94e-05	0.000741	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.82e-05	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.82e-05	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	6.8e-05	0.000726	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.68e-05	0.000714	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.57e-05	0.000701	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.54e-05	0.000698	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.52e-05	0.000696	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.47e-05	0.000691	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.43e-05	0.000686	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.43e-05	0.000686	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.38e-05	0.000681	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.38e-05	0.000681	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	6.36e-05	0.000679	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.33e-05	0.000676	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.33e-05	0.000676	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	6.15e-05	0.000657	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6e-05	0.00064	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.92e-05	0.000632	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.87e-05	0.000627	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.87e-05	0.000627	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IL2—acquired immunodeficiency syndrome	5.83e-05	0.000623	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.79e-05	0.000618	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.79e-05	0.000618	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.75e-05	0.000614	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.67e-05	0.000605	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.58e-05	0.000596	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.42e-05	0.000579	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.31e-05	0.000567	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.31e-05	0.000567	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.3e-05	0.000566	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.19e-05	0.000554	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.18e-05	0.000553	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.11e-05	0.000546	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.1e-05	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.1e-05	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.07e-05	0.000542	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.07e-05	0.000541	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.03e-05	0.000538	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.99e-05	0.000533	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.99e-05	0.000533	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.99e-05	0.000533	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.99e-05	0.000533	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ALB—acquired immunodeficiency syndrome	4.84e-05	0.000517	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.67e-05	0.000499	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.6e-05	0.000492	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.57e-05	0.000488	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.88e-05	0.000414	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.87e-05	0.000413	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.86e-05	0.000412	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.84e-05	0.00041	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.82e-05	0.000408	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.8e-05	0.000405	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.8e-05	0.000405	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.76e-05	0.000402	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.74e-05	0.000399	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.74e-05	0.000399	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.68e-05	0.000393	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.68e-05	0.000393	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.5e-05	0.000373	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.42e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.42e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.42e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.35e-05	0.000357	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.35e-05	0.000357	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.23e-05	0.000345	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.99e-05	0.00032	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.98e-05	0.000318	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.7e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.69e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.27e-05	0.000242	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.02e-05	0.000216	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.01e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.98e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.98e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.97e-05	0.00021	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.97e-05	0.00021	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.76e-05	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.59e-05	0.000169	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.26e-05	0.000135	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000127	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000124	CbGpPWpGaD
